 |
|
|
| |
DISCOVER in Europe: a Subanalysis of the Phase 3, Randomized, Controlled Trial of Daily Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Pre-exposure Prophylaxis
|
| |
| |
17th European AIDS Conference (EACS), 6-9 November 2019, Basel, Switzerland
Reported by Jules Levin
Frank Post,1 Christoph Spinner,2 Pep Coll,3 Trevor Hawkins,4 Jonathon Anderson,4 Lijie Zhong,4 Scott McCallister4
1King's College Hospital, London, UK; 2Klinikum rechts der Isar, Technische Universität München Fakultät für Medizin, München, Germany; 3BCN Checkpoint, IrsiCaixa AIDS Institut de Recerca de la Sida, Barcelona, Spain; 4Gilead Sciences, Inc., Foster City, California, USA
References: 1. Descovy [package insert]. Foster City, CA: Gilead Sciences, Inc.: 10/2019; 2. Hare CB, et al. CROI 2019. abstr 104; 3. Hayes R, et al. Euro Surveillance. 2019 Oct;24.
|
| |
|
|
|
|
|
